ArticleMicroorganisms2024
Clinical Manifestations, Macrolide Resistance, and Treatment Utilization Trends of
Abstract read
In one paragraph
Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Neutrophil-to-lymphocyte ratio mediates pulmonary consolidation through oxidative stress in children withAnnals of medicine · 2026Article
- Development of a Real-Time Polymerase Chain Reaction Assay to DetectDiagnostics (Basel, Switzerland) · 2026Article
- East Asia as a sentinel: risk-stratified corticosteroid therapy for paediatric macrolide-resistantEuropean respiratory review : an official journal of the European Respiratory Society · 2026Review
- Diagnostic Accuracy of Serological Tests forAnnals of laboratory medicine · 2026Article
- Construction of a nomogram combining CT and serum markers for predicting macrolide resistance gene mutation status in pediatric Mycoplasma pneumoniae pneumonia.Frontiers in pediatrics · 2026Article
- Immunopathogenesis, molecular phenotyping, and host-directed interventions for severe pediatricFrontiers in cellular and infection microbiology · 2026Review
- Explainable machine learning for diagnosing severeFrontiers in pediatrics · 2026Article
- Direct hospitalization costs of children withFrontiers in public health · 2026Article
- Nomogram to predict severeFrontiers in pediatrics · 2026Article
- The impact of the COVID-19 pandemic on the epidemiology, clinical manifestations and molecular characteristics ofFrontiers in immunology · 2026Review
- Clinical characteristics of hospitalized children with mycoplasma pneumoniae pneumonia in Chinese tertiary hospitals during the 2023-2024 post-pandemic period.Frontiers in cellular and infection microbiology · 2026Article
- Growing Threat of Macrolide-ResistantJournal of Korean medical science · 2025Review
- Article
- Macrolide-ResistantMicroorganisms · 2025Article
- Treatment modalities for fever duration in children with Mycoplasma pneumoniae pneumonia.Scientific reports · 2025Article
- Clinical Characteristics and Treatment Outcomes of Pediatric Drug-ResistantInfection and drug resistance · 2025Article
- New Insights into the Epidemiological Characteristics ofMicroorganisms · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Joon Kee LeeDepartment of Pediatrics, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju 28644, Republic of Korea.ORCID 0000-0001-8191-0812
Taekjin LeeDepartment of Pediatrics, CHA Bundang Medical Center, CHA University, Seongnam 13496, Republic of Korea.ORCID 0000-0002-8912-6982
Yae-Jean KimDepartment of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyungwan University, Seoul 06351, Republic of Korea.
Doo Ri KimDepartment of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyungwan University, Seoul 06351, Republic of Korea.
Areum ShinDepartment of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyungwan University, Seoul 06351, Republic of Korea.
Hyun Mi KangDepartment of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0003-0513-8407
Ye Ji KimDepartment of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Dong Hyun KimDepartment of Pediatrics, Inha University College of Medicine, Incheon 22212, Republic of Korea.
Byung Wook EunDepartment of Pediatrics, Eulji University Eulji General Hospital, Seoul 01830, Republic of Korea.ORCID 0000-0003-3147-9061
Young June ChoeDepartment of Pediatrics, Korea University Anam Hospital, and Allergy and Immunology Center, Korea University, Seoul 02841, Republic of Korea.
Hyunju LeeDepartment of Pediatrics, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.ORCID 0000-0003-0107-0724
Young Min ChoDepartment of Pediatrics, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.ORCID 0000-0002-0987-4180
Eun Young ChoDepartment of Pediatrics, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.
Kyung Min KimDepartment of Pediatrics, Chungnam National University Hospital, Daejeon 35015, Republic of Korea.
Byung Ok KwakDepartment of Pediatrics, Hallym University Kangnam Sacred Heart Hospital, Seoul 07441, Republic of Korea.
Su Eun ParkDepartment of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.
Kyo Jin JoDepartment of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.
Jae Hong ChoiDepartment of Pediatrics, Jeju National University School of Medicine, Jeju 63243, Republic of Korea.
Dayun KangDepartment of Pediatrics, Seoul National University Children's Hospital, Seoul 03080, Republic of Korea.
Eun Hwa ChoiDepartment of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0002-5857-0749
Ki Wook YunDepartment of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0002-0798-6779
Funding
Korea Disease Control and Prevention Agency 2023090EDDAKorean Society of Pediatric Infectious Diseases N/A
Abstract
A resurgence of
Indexed as
adolescentchildmacrolidesmycoplasma pneumoniae
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.